---
title: "KTC: The KTC brand showcases the latest released product, AI interactive glasses"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/224398445.md"
description: "KTC showcased its latest AI interactive glasses at CES 2025, which integrate multiple technologies to enhance user experience. At the same time, KTC also launched several gaming monitors and smart displays to meet consumer demands"
datetime: "2025-01-09T05:24:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/224398445.md)
  - [en](https://longbridge.com/en/news/224398445.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/224398445.md)
generator: "portal-rs"
---

# KTC: The KTC brand showcases the latest released product, AI interactive glasses

KTC announced today on its official Weibo that the CES 2025, known as the "Spring Festival Gala of the Technology Industry," has opened in Las Vegas, USA. AI is the theme of this event, and the KTC brand showcased its newly released AI interactive glasses, which integrate multiple technologies such as large model intelligence, anti-shake, and live streaming. To meet the growing demands of consumers, KTC continues to upgrade its products to provide users with an even better experience. In addition, the KTC brand also brought several key products, including high-refresh esports, curved esports, high-end dual-mode esports, and 5K esports

### Related Stocks

- [001308.CN](https://longbridge.com/en/quote/001308.CN.md)
- [002429.CN](https://longbridge.com/en/quote/002429.CN.md)

## Related News & Research

- [REG - Tudor Cap Eur LLP JTC PLC - Form 8.3 - JTC Plc](https://longbridge.com/en/news/296492968.md)
- [STARPRIME Completes Beta Testing of Market-Maker Model for Retail Brokers](https://longbridge.com/en/news/296307363.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [Boulos sees Greater Portland office market return to positive net absorption in 2026 midyear outlook](https://longbridge.com/en/news/296524941.md)
- [CDC lifts beneficial stake in Exosens to 11.71% of capital, 13.87% of voting rights](https://longbridge.com/en/news/296499698.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**